what is glp-1 agonist therapy Receptor Agonists as Treatments for Type 2 Diabetes GLP- 1 Agonist Therapy Center
Description
how far findings apply to non-diabetic, normal weight older adults remains unknown
Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.
Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.
The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health Organization guidelines.
